Beck Bode, LLC Exact Sciences Corp Transaction History

Beck Bode, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$65.94 - $99.04 $105,042 - $157,770	-1,593 Reduced 2.94%	52,603 $3.59 Million
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $2.61 Million - $3.96 Million	41,672 Added 332.74%	54,196 $5.09 Million
Q1 2023 May 03, 2023	SELL	$47.19 - $70.77 $784,486 - $1.18 Million	-16,624 Reduced 57.03%	12,524 $849,000
Q4 2022 Feb 07, 2023	BUY	$30.35 - $53.15 $884,641 - $1.55 Million	29,148 New	29,148 $1.44 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.